Oxaliplatin Withdrawn Phase 2 Trials for Cholangiocarcinomas Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00713687Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma